Pubblicazioni 2012

Pubblicazioni dell’IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS.

Per ulteriori informazioni scrivere a:

direzionescientifica@fondazionebietti.it

1) Digiuni M, Fogagnolo P, Rossetti L. 

A review of the use of latanoprost for glaucoma since its launch. 

Expert Opin Pharmacother. 2012 Apr;13(5):723-45. 

 

2)Fogagnolo P, Sacchi M, Ceresara G, Paderni R, Lapadula P, Orzalesi N, Rossetti L. 

The Effects of Topical Coenzyme Q(10) and Vitamin E d-alpha-Tocopheryl Polyethylene Glycol 1000 Succinate after Cataract Surgery: A Clinical and in vivo Confocal Study. 

Ophthalmologica. 2013;229(1):26-31 

 

3)Vetrugno M, Uva MG, Russo V, Iester M, Ciancaglini M, Brusini P, Centofanti M, Rossetti LM. 

Oral Administration of Forskolin and Rutin Contributes to Intraocular Pressure Control in Primary Open Angle Glaucoma Patients Under Maximum Tolerated Medical Therapy. J 

Ocul Pharmacol Ther. 2012 Oct;28(5):536-41. 

 

4)Fogagnolo P, Centofanti M, Figus M, Frezzotti P, Fea A, Ligorio P, Lembo A, Digiuni M, Lorenzi U, Rossetti L. 

Short-Term Changes in Intraocular Pressure after Phacoemulsification in Glaucoma Patients. 

Ophthalmologica. 2012;228(3):154-8. 

 
5)Izzotti A, Centofanti M, Saccà SC. 

Molecular diagnostics of ocular diseases: the application of antibody microarray. 

Expert Rev Mol Diagn. 2012 Jul;12(6):629-43. 

 

6)Digiuni M, Manni G, Vetrugno M, Uva M, Milano G, Orzalesi N, Fogagnolo P, Centofanti M, Ca-mpos E, Rossetti L. 

An Evaluation of Therapeutic Noninferiority of 0.005% Latanoprost Ophthalmic Solution and Xalatan in Patients With Glaucoma or Ocular Hypertension. 

J Glaucoma. 2012 May 16. DOI: 10.1097/IJG.0b013e318259b47c. 

 

7)Saccà SC, Centofanti M, Izzotti A. 

New proteins as vascular biomarkers in primary open angle glaucomatous aqueous humor. 

Invest Ophthalmol Vis Sci. 2012 Jun 28;53(7):4242-53. 

 

8)Parisi V, Ziccardi L, Centofanti M, Tanga L, Gallinaro G, Falsini B, Bucci MG. 

Macular function in eyes with open-angle glaucoma evaluated by multifocal electroretinogram. 

Invest Ophthalmol Vis Sci. 2012 Oct 9;53(11):6973-80 

 
9)Bagnis A, Izzotti A, Centofanti M, Saccà SC. 

Aqueous humor oxidative stress proteomic levels in primary open angle glaucoma. 

Exp Eye Res. 2012 Oct;103:55-62. (IF.:3.026; Disciplina Ophthalmology quartile primo; terzo nome 50% IFN 3). 

 

10)Marangoni D, Falsini B, Colotto A, Salgarello T, Anselmi G, Fadda A, Di Renzo A, Campos EC, Riva CE. 

Subfoveal choroidal blood flow and central retinal function in early glaucoma. 

Acta Ophthalmol. 2012 Jun;90(4):e288-94.

1)Parodi MB, Iacono P, De Benedetto U, Cascavilla M, Bandello F. 

Rebound effect after intravitreal dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion. 

J Ocul Pharmacol Ther. 2012 Dec;28(6):566-8  (IF.:1.293; Disciplina Ophthalmology quartile secondo; IFN 4). 

 

2)De Benedetto U, Battaglia Parodi M, Knutsson KA, Librando A, Bandello F, Lanzetta P, Iacono P. 

Intravitreal Bevacizumab for Extrafoveal 

Choroidal Neovascularization After Ocular Trauma. J Ocul Pharmacol Ther. 2012 Oct;28(5):550-2. Epub 2012 May 3. 

 
3)Battaglia Parodi M, Cascavilla M, Papayannis A, Kontadakis DS, Bandello F, Iacono P. 

Intravitreal bevacizumab in advanced stage neovascular age-related macular degeneration with visual acuity lower than 20/200. 

Arch Ophthalmol.2012 Jul 1;130(7):934-5. 

 
4)Parravano M, Sciamanna M, Giorno P, Boninfante A, Varano M. 

Bietti crystalline dystrophy: a morpho-functional evaluation. 

Doc Ophthalmol. 2012 Feb;124(1):73-7. 

 
5)Reibaldi M, Parravano M, Varano M, Longo A, Avitabile T, Uva MG, Zagari M. Toro M, Boscia F, Boccassini B, Chiaravalloti A, Mariotti C, Reibaldi A. 

Foveal microstructure anf functional parameters in lamellar macular hole. 

Am J Ophthalmol. 2012 Dec;154(6):974-980  

 
6)Parravano M, Oddone F, Boccassini B, Chiaravalloti A, Scarinci F, Sciamanna M, Boninfante A, Tedeschi M, Varano M. 

Functional and structural assessment of lamellar macular holes. 

Br J Ophthalmol. 2012. DOI: 10.1136/bjophthalmol-2011-301219. 

 
7)Bandello F, Berchicci L, La Spina C, Battaglia Parodi M, Iacono P. 

Evidence for anti-VEGF Treatment of Diabetic Macular Edema. 

Ophthalmic Res. 2012;48 Suppl 1:16-20. Epub 2012 Aug 21. 

 

8)Battaglia Parodi M, Iacono P, Pierro L, Papayannis A, Kontadakis S, Bandello FM. 

Subthreshold laser treatment versus threshold laser treatment for symptomatic retinal arterial macroaneurysm. 

Invest Ophthalmol Vis Sci. 2012 Apr 2;53(4):1783-6. 

 

9)Battaglia Parodi M, Iacono P, Kontadakis S, Vergallo S, Cascavilla M, Zucchiatti I, Bandello F. 

Retro-mode Imaging and Fundus Autofluorescence with Scanning Laser. 
 
Ophthalmoscope of Retinal Dystrophies. BMC Ophthalmol.2012 May 15;12(1):8. 

 

10)Scarinci F, Mezzana P, Pasquini P, Colletti M, Cacciamani A. 

Central chorioretinopathy associated with topical use of minoxidil 2% for treatment of baldness. 

Cutan Ocul Toxicol 2012 Jun;31(2):157-9. 

 

11)Iacono P, Parodi MB, Papayannis A, Kontadakis S, Sheth S, Cascavilla ML, Bandello F. 

Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularization. 

Retina.2012 Sep;32(8):1539-46.  

 
12)Midena E, Vujosevic S. 

Diagnosing and monitoring diabetic macular edema: structural and functional tests. 

Int Ophthalmol. 2012 DOI: 10.1007/s10792-012-9566-9 (IF.:0; Disciplina Ophthalmology, rivista senza IF; IFN: 0.1) 

 
13)Battaglia Parodi M, De Benedetto U, Knutsson KA, Scotti F, Librando A, Bandello F, Iacono P. 

Juxtafoveal choroidal neovascularization associated with retinitis pigmentosa treated with intravitreal bevacizumab. 

JOcul Pharmacol Ther. 2012 Apr;28(2):202-4. 

 

14)Bandello F, De Benedetto U, Knutsson K, Battaglia Parodi M, Cascavilla M, Iacono P. 

Evidence for anti-vascular endothelial growth factor treatment of diabetic macular oedema 

European Endocrinology 2012. 8: 36-41. 

 

15)Larsen M, Schmidt-Erfurth U, Lanzetta P, Wolf S, Simader C, Tokaji E, Pilz S, Weisberger A, Mont Blanc Study Group, Varano M. 

Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month Mont Blnc study results. 

Ophthalmology. 2012 May;119(5):992-1000. 

 

16)Virgili G, Parravano M, Menchini F, Brunetti M. 

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema: Cochrane systematic review. 

Cochrane Database Syst Rev Dec 12;12:CD007419. 

 

17)Rossi T, Boccassini B, Esposito L, Clemente C, Iossa M, Placentino L, Bonora N. 

Primary Blast Injury to the Eye: Finite Element Modeling. 

Invest Ophthalmol Vis Sci. 2012 Dec 7;53(13):8057-66. 

1)Lamoke F, Ripandelli G, Webster S, Montemari A, Maraschi A, Martin P, Marcus DM, Liou GI, Bartoli M. 
 
Loss of thioredoxin function in retinas of mice overexpressing amyloid beta 

Free Radic Biol Aug 1;53(3):577-88. 

 

2)Ripandelli G, Rossi T, Scarinci F, Scassa C, Parisi V, Stirpe M. 

Macular Vitreo-Retinal Interface Abnormalities in Highly Myopic Eyes with Posterior Staphyloma: 5-Years Follow-Up. 

Retina 2012 Retina. 2012 Sep;32(8):1531-8. 

 
3)Scassa C, Cupo G, Bruno M, Iervolino R, Scarinci F, Giusti C. 

Early lamellar macular hole in Alport syndrome: case report and review of the literature. 

Eur Rev Med Pharmacol Sci. 2012 Jan;16(1):122-5. 

 
4)Rossi T, Querzoli G, Pasqualitto G, Iossa M, Placentino L, Repetto R, Stocchino A, Ripandelli G. 

Ultrasound imaging velocimetry of the human vitreous. 

Exp Eye Res. 2012 Jun;99(1):98-104. 

 
5)Stirpe M, Ripandelli G, Rossi T, Cacciamani A, Orciuolo M. 

A new adjustable macular buckle designed for highly myopic eyes. 

Retina. 2012 Jul;32(7):1424-7. 

 
6)Scassa C, Cupo G, Bruno M, Iervolino R, Capozzi S, Tempesta C, Giusti C. 

Optical devices in highly myopic eyes with low vision: A prospective study. 

Clin Ter. 2012 May;163(3):e115-20. 

1)Savini G, Barboni P, Carbonelli M, Hoffer KJ. 

Accuracy of corneal power measurements by a new Scheimpflug camera combined with Placido-disk corneal topography for intraocular lens power calculation in unoperated eyes. 

J Cataract Refract Surg. 2012 May;38(5):787-92. 

 
2)Savini G, Hoffer KJ. 

Toric intraocular lens calculations. 

Arch Ophthalmol 2012;130:947-949. 

 
3)Ferrari G, Reichegger V, Ludergnani L, Delfini E, Macaluso C. 

In vivo evaluation of DSAEK interface with scanning-laser confocal microscopy. 

BMC Ophthalmol. 2012 Aug 1;12:32. 

 
4)Tranchina L, Lombardo M, Oddone F, Serrao S, Lomoriello DS, Ducoli P. 

Influence of Corneal Biomechanical Properties on Intraocular Pressure Differences Between an Air-Puff Tonometer and the Goldmann Applanation Tonometer. 

J Glaucoma. 2012 DOI 10.1097/IJG.0b013e31824cafc9. 

 
5)Wang Q, Savini G, Hoffer K, Xu Z, Feng Y, Wen D, HuaY, Yang F, Pan C, Huang J. 

A Comprehensive Assessment of the Precision and Agreement of Anterior Corneal Power Measurements Obtained Using 8 Different Devices. 

PLOS One 2012, DOI: 10.1371/journal.pone.0045607.  

 
6)Camellin M, Savini G, Hoffer KJ, Carbonelli M, Barboni P. 

Scheimpflug camera measurement of anterior and posterior corneal curvature in eyes with previous radial keratotomy. 

J Refract Surg. 2012 Apr;28(4):275-9. 

 
7)Serrao S, Buratto L, Lombardo G, De Santo MP, Ducoli P, Lombardo M. 
 
Optimal parameters to improve the interface quality of the flap bed in femtosecond laser assisted LASIK. 

J Cataract Refract Surg 2012; 38(8): 1453-1459. 

 
8)Serrao S, Lombardo M, De Santo MP, Lombardo G, Schiano Lomoriello D, Ducoli P, Stirpe M. 

Femtosecond laser photodisruptive effects on the posterior human corneal stroma investigated with atomic force microscopy. 

Eur J Ophthalmol. 2012 Jul;22 Suppl 7:89-97. 

 
9)Lombardo M, Serrao S, Ducoli P, Lombardo G. 

Variations in image optical quality of the eye and the sampling limit of resolution of the cone mosaic with axial length in young adults. 

J Cataract Refract Surg. 2012 Jul;38(7):1147-55. 

 

10)Lombardo M, Lombardo G, Carbone G, De Santo MP, Barberi R, Serrao S. 

Biomechanics of the anterior human corneal tissue investigated with atomic force microscopy. 

Invest Ophthalmol Vis Sci. 2012 Feb 29;53(2):1050-7. 

 
11)Stevenson W, Cheng SF, Dastjerdi MH, Ferrari G, Dana R. 

Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). 

Ocul Surf. 2012 Apr;10(2):67-83. Epub 2012 Jan 25. Review. 

 
12)Lombardo M, De Santo MP, Lombardo G, Schiano Lomoriello D, Desiderio G, Ducoli P, Barberi R, Serrao S. 

Surface Quality of Femtosecond Dissected Posterior Human Corneal Stroma Investigated With Atomic Force Microscopy. 

Cornea 2012; 31(12):1369-1375. 

 
13)Cheng SF, Dastjerdi MH, Ferrari G, Okanobo A, Bower KS, Ryan DS, Amparo F, Stevenson W, Hamrah P, Nallasamy N, Dana R. 

Short-Term Topical Bevacizumab in the Treatment of Stable Corneal Neovascularization. 

Am J Ophthalmol 2012; 154(6):940-948. 

 
14)Pescina S, Santi P, Ferrari G, Padula C, Cavallini P, Govoni P, Nicoli S. 
 
Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery. 

Eur J Pharm Sci. 2012 Aug 15;46(5):475-83. 

 

15)Lombardo M, Serrao S, Ducoli P, Lombardo G. 

Adaptive optics photoreceptor imaging. 
 
Ophthalmology 2012; 119(7): 1498-198e2. 

 

16)Bianchi E, Scarinci F, Grande C, Plateroti R, Plateroti P, Plateroti AM, Fumagalli L, Capozzi P, Feher J, Artico M. 

Immunohistochemical profile of VEGF, TGF-beta and PGE2 in human pterygium and normal conjunctiva: experimental study and review of the literature. 

Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):607-15. 

 

17)Micera A, Puxeddu I, Balzamino BO, Bonini S, Levi-Schaffer F. 

Chronic nerve growth factor exposure increases apoptosis in a model of in vitro induced conjunctival myofibroblasts. 

PLoS One. 2012;7(10):e47316. Epub 2012 Oct 10. 

 

18)Huang J, Wang Q, Savini G. 

Comparison of intraocular pressure measurement using 4 different instruments following penetrating keratoplasty (letter). 

Am J Ophthalmol. 2012 Mar;153(3):580; author reply 580-1. 

 

19)Arbelaez MC, Versaci F, Vestri G, Barboni P, Savini G. 

Use of a support vector machine for keratoconus and subclinical keratoconus detection by topographic and tomographic data. 

Ophthalmology 2012;119:2231-2238. 

 
20)Fogagnolo P, Colletti G, Valassina D, Allevi F, Rossetti L. 

Partial and total lower lid reconstruction: our experience with 41 cases. 

Ophthalmologica. 2012;228(4):239-43. 

 

21)Cupo G, Scarinci F, Ripandelli G, Sampalmieri M, Giusti C. 

Changes in vital signs during cataract phacoemulsification by using peribulbar or topical anesthesia. 

Clin Ter. 2012 Sep;163(5):e263-7. 

 

22)Ueno H, Ferrari G, Hattori T, Saban DR, Katikireddy KR, Chauhan SK, Dana R. 

Dependence of corneal stem/progenitor cells on ocular surface innervation. 

Invest Ophthalmol Vis Sci. 2012 Feb 21;53(2):867-72. 

 

23)Angelucci C, Maulucci G, Lama G, Proietti G, Colabianchi A, Papi M, Maiorana A, De Spirito M, Micera A, Balzamino OB, Di Leone A, Masetti R, Sica G. 

Epithelial-stromal interactions in human breast cancer: effects on adhesion, plasma membrane fluidity and migration speed and directness. 

PLoS One. 2012;7(12):e50804. Epub 2012 Dec 10. 

1)Vujosevic S, Trento B, Bottega E, Urban F, Pilotto E, Midena E. 

Scanning laser ophthalmoscopy in the retromode in diabetic macular oedema. 

Acta Ophthalmol. 2012 Aug;90(5):e374-80 

 
2)Vujosevic S, Martini F, Pilotto E, Cavarzeran F, Midena E. 

Macular and Peripapillary Choroidal Thickness in Diabetic Patients. 

Retina. 2012 Oct;32(9):1781-90. 

 
3)Vujosevic S, Tempesta D, Noventa F, Midena E, Sebastiani G. 

Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening. 

Hepatology. 2012 Aug;56(2):455-63 

 
4)Midena E, Parrozzani R. 

Biopsies in uveal melanoma.  

Dev Ophthalmol. 2012;49:81-95. 

 

UR Neurofisiologia della Visione e Neuroftalmologia 
1)Barone I, Novelli E, Piano I, Gargini C, Strettoi E. 

Environmental enrichment extends photoreceptor survival and visual function in a mouse model of retinitis pigmentosa. 

PLoS One. 2012;7(11):e50726.  

 
2)Santina LD, Piano I, Cangiano L, Caputo A, Ludwig A, Cervetto L, Gargini C. 

Processing of retinal signals in normal and HCN deficient mice. 

PLoS One. 2012;7(1):e29812. 

 
3)Savini G, Barboni P, Carbonelli M, Sbreglia A, Deluigi G, Parisi V. 

Comparison of Optic Nerve Head Parameter Measurements Obtained by Time-domain and Spectral-domain Optical Coherence Tomography. 

J Glaucoma. 2012 Feb 24. [Epub ahead of print] doi: 10.1097/IJG.0b013e31824c9423 

 
4)Huang J, Wang Q, Savini G. 

Evaluation of the nerve fiber layer and macula in the eyes of healthy children using spectral-domain optical coherence tomography (letter). 

Am J Ophthalmol. 2012 Apr;153(4):774; author reply 774-5. 

 
5)Huang J, Savini G, Feng Y, Wang Q. 

Retinal nerve fiber layer thickness measurements in rats with spectral domain-optical coherence tomography (letter). 

Invest Ophthalmol Vis Sci. 2012 Feb 13;53(2):749-50. 

 

6)Falsini B, Galli-Resta L, Fadda A, Ziccardi L, Piccardi M, Iarossi G, Resta G. 

Long-Term Decline of Central Cone Function in Retinitis Pigmentosa Evaluated by Focal Electroretinogram. 

Invest Ophthalmol Vis Sci. 2012 Nov 19;53(12):7701-9. 

 

7)Coppola G, Schoenen J. 

Cortical excitability in chronic migraine. 

Cur Pain Headache Rep 2012; 16: 93-100. 

 

8)Coppola G, Schoenen J. 

Management of acute and chronic migraine. 

Curr Opin Supp Pall Care 2012 6(2):177-182. 

 

9)Barboni P, Savini G, Feuer WJ, Budenz DL, Carbonelli M, Chicani F, Ramos CD, Salomao SR, De Negri A, Parisi V, Carelli V, Sadun AA. 

Retinal nerve fiber layer thickness variability in Leber hereditary optic neuropathy carriers. 

Eur J Ophthalmol. 2012;22(6):985-991. 

 

10)Vijayasarathy C, Ziccardi L, Sieving PA. 
Biology of retinoschisin. 

Adv Exp Med Biol. 2012;723:513-8. 

 
11)Coppola G, De Pasqua V, Pierelli F, Schoenen J. 

Effects of repetitive transcranial magnetic stimulation on somatosensory evoked potentials and high frequency oscillations in migraine. 

Cephalalgia. 2012;32:700–709. 

 

12)Ziccardi L, Vijayasarathy C, Bush RA, Sieving PA. 

Loss of Retinoschisin (RS1) Cell Surface Protein in Maturing Mouse Rod Photoreceptors Elevates the Luminance Threshold for Light-Driven Translocation of Transducin But Not Arrestin. 

J Neurosci. 2012 Sep 19;32(38):13010-21. 

 
13)Magis D, Boon E, Coppola G, Daron A, Schoenen J. 

A novel CACNA1A mutation results in episodic ataxia with migrainous features without headache. 

Cephalalgia 2012;32(15):1147-9. 

 
14)Marazziti D, Baroni S, Pirone A, Giannaccini G, Betti L, Schmid L, Vatteroni E, Palego L, Borsini F, Bordi F, Piano I, Gargini C, Castagna M, Catena-Dell’osso M, Lucacchini A. 

Distribution of serotonin receptor of type 6 (5-HT6) in human brain post-mortem. A pharmacology, autoradiography and immunohistochemistry study. 

Neurochem Res. 2012 May;37(5):920-7 

 
15)Iacovelli E, Coppola G, Tinelli E, Pierelli F, Bianco F. 

Neuroimaging in cluster headache and other trigeminal-autonomic cephalalgias. 

J Headache Pain 2012;13(1):11-20. 

 

16)Huang J, Savini G, Chen S, Feng Y, Wang Q. 

Choroidal thickness measurements. 

Ophthalmology. 2012 Jun;119(6):1286.  

 
17)Restani L, Novelli E, Bottari D, Leone P, Barone I, Galli-Resta L, Strettoi E, Caleo M. 

Botulinum Neurotoxin A Impairs Neurotransmission Following Retrograde Transynaptic Transport. 

Traffic. 2012;13(8):1083-9. 

 

18)Wang Q, Savini G, Hoffer KJ, Xu Z, Feng Y, Wen D, Hua Y, Yang F, Pan C, Huang J. 

A comprehensive assessment of the precision and agreement of anterior corneal power measurements obtained using 8 different devices. 

Plos One 2012;7(9):e45607.